| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ty Hergenreder, Tao Yang, Bing Y. The role of Down syndrome cell adhesion molecule in Down syndrome. Medical review (2021). vol 4. issue 1. 2024-03-22. PMID:38515781. |
among the genes located in the ds "critical region" of hsa21, down syndrome cell adhesion molecule (dscam) plays an important role in neuronal development. |
2024-03-22 |
2024-03-24 |
human |
| E Fucà, F Costanzo, P Galassi, L Celestini, D Valentini, S Vicar. Celiac disease in children and adolescents with Down syndrome: behavioural, adaptive and sleep profiles. Journal of intellectual disability research : JIDR. 2024-03-21. PMID:38509762. |
individuals with down syndrome (ds) exhibit higher risk for celiac disease (cd) than general population. |
2024-03-21 |
2024-03-23 |
Not clear |
| Daniel J Kats, Karen Donelan, Souvik Banerjee, Gert de Graaf, Ellen Skladzien, Brian Takashi Hooper, Rose Mordi, Tetiana Mykhailenko, Frank Buckley, Stephanie L Santoro, Vasiliki Patsiogiannis, Kavita Krell, Kelsey Haugen, Brian G Skotk. Results of inaugural international Down Syndrome Societal Services and Supports survey. Genetics in medicine : official journal of the American College of Medical Genetics. 2024-03-21. PMID:38512346. |
we previously designed the down syndrome societal services and supports survey (ds-4s) to measure country-specific supports for people with down syndrome (ds) across multiple life domains (healthcare, education, policy, independence, and community inclusion). |
2024-03-21 |
2024-03-23 |
Not clear |
| Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki, Rika Kanezaki, Kiminori Terui, Ryunosuke Saiki, Masami Ojima, Yotaro Ochi, Seiya Mizuno, Masaharu Yoshihara, Tamayo Uechi, Naoya Kenmochi, Shiro Tanaka, Jun Matsubayashi, Kenta Kisai, Ko Kudo, Kentaro Yuzawa, Yuka Takahashi, Tatsuhiko Tanaka, Yohei Yamamoto, Akie Kobayashi, Takuya Kamio, Shinya Sasaki, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Hideki Muramatsu, Asahito Hama, Daisuke Hasegawa, Atsushi Sato, Katsuyoshi Koh, Shuhei Karakawa, Masao Kobayashi, Junichi Hara, Yuichi Taneyama, Chihaya Imai, Daiichiro Hasegawa, Naoto Fujita, Masahiro Yoshitomi, Shotaro Iwamoto, Genki Yamato, Satoshi Saida, Nobutaka Kiyokawa, Takao Deguchi, Masafumi Ito, Hidemasa Matsuo, Souichi Adachi, Yasuhide Hayashi, Takashi Taga, Akiko Moriya Saito, Keizo Horibe, Kenichiro Watanabe, Daisuke Tomizawa, Satoru Miyano, Satoru Takahashi, Seishi Ogawa, Etsuro It. Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms. Blood. 2024-03-21. PMID:38513239. |
transient abnormal myelopoiesis (tam) is a common complication in newborns with down syndrome (ds). |
2024-03-21 |
2024-03-24 |
Not clear |
| Debomoy K Lahiri, Deborah K Soko. Alzheimer's Drugs APPlication for Down syndrome? Ageing research reviews. 2024-03-21. PMID:38513771. |
accumulation of the amyloid β (aβ) peptide, derived from aβ precursor protein (app), is a trait of down syndrome (ds), as is early development of dementia like alzheimer's disease (ad). |
2024-03-21 |
2024-03-24 |
human |
| Frode Kibsgaard Larsen, R Asaad Baksh, Eimear McGlinchey, Ellen Melbye Langballe, Bessy Benejam, Jessica Beresford-Webb, Mary McCarron, Antonia Coppus, Segolene Falquero, Juan Fortea, Johannes Levin, Sandra V Loosli, Ruth Mark, Anne-Sophie Rebillat, Shahid Zaman, Andre Strydo. Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2024-03-20. PMID:38506627. |
people with down syndrome (ds) have high risk of developing alzheimer's disease (ad). |
2024-03-20 |
2024-03-23 |
Not clear |
| Doug Chieffe, Christopher Hartnic. Neurostimulation for Pediatric Obstructive Sleep Apnea. Otolaryngologic clinics of North America. 2024-03-20. PMID:38508882. |
up to 80% of children with down syndrome (ds) are affected by obstructive sleep apnea (osa), and only 16% to 30% will have resolution of their osa with adenotonsillectomy. |
2024-03-20 |
2024-03-23 |
Not clear |
| Nicole T Baumer, Katherine G Pawlowski, Bo Zhang, Georgios Sideridi. Validation of factor structure of the neurodevelopmental parent report for outcome monitoring in down syndrome: confirmatory factor analysis. Frontiers in psychiatry. vol 15. 2024-03-20. PMID:38505792. |
the neurodevelopmental parent report for outcome monitoring (nd-prom), initially developed to monitor developmental and behavioral functions in children with autism spectrum disorder (asd), assesses symptoms across a wide range of domains relevant in down syndrome (ds). |
2024-03-20 |
2024-03-23 |
Not clear |
| Morgan Dykman, Madison Ernst, Tasya Rakasiwi, Amy Buros Stein, David J Satin, Kristen E Holland, Stephanie L Santoro, Jillian F Ror. Dermatology Life Quality Index survey in patients with Down syndrome and caregivers. Pediatric dermatology. 2024-03-19. PMID:38500261. |
down syndrome (ds) is associated with many dermatological conditions, including hidradenitis suppurativa, folliculitis, and alopecia areata. |
2024-03-19 |
2024-03-21 |
Not clear |
| Praveen N K Pitchan Velammal, Suryakumar Balasubramanian, Fathima Shehnaz Ayoobkhan, Gautham V K Mohan, Pearl Aggarwal, Ali A Rabaan, Syed A Khan, Farah Yasmin, Thoyaja Koritala, Salim R Suran. COVID-19 in patients with Down syndrome: A systematic review. Immunity, inflammation and disease. vol 12. issue 3. 2024-03-19. PMID:38501534. |
down syndrome (ds) is associated with multiple comorbid conditions and chronic immune dysfunction. |
2024-03-19 |
2024-03-21 |
Not clear |
| Sergi Llambrich, Birger Tielemans, Ellen Saliën, Marta Atzori, Kaat Wouters, Vicky Van Bulck, Mark Platt, Laure Vanherp, Nuria Gallego Fernandez, Laura Grau de la Fuente, Harish Poptani, Lieve Verlinden, Uwe Himmelreich, Anca Croitor, Catia Attanasio, Zsuzsanna Callaerts-Vegh, Willy Gsell, Neus Martínez-Abadías, Greetje Vande Veld. Pleiotropic effects of trisomy and pharmacologic modulation on structural, functional, molecular, and genetic systems in a Down syndrome mouse model. eLife. vol 12. 2024-03-18. PMID:38497812. |
down syndrome (ds) is characterized by skeletal and brain structural malformations, cognitive impairment, altered hippocampal metabolite concentration and gene expression imbalance. |
2024-03-18 |
2024-03-20 |
mouse |
| Hampus Hillerstrom, Richard Fisher, Matthew P Janicki, Brian Chicoine, Bradley T Christian, Anna Esbensen, Lucille Esralew, Juan Fortea, Sigan Hartley, Jason Hassenstab, Seth M Keller, Sharon Krinsky-McHale, Florence Lai, Johannes Levin, Mary McCarron, Eric McDade, Anne Sophie Rebillat, Herminia Diana Rosas, Wayne Silverman, Andre Strydom, Shahid H Zaman, Henrik Zetterber. Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2024-03-14. PMID:38480678. |
this overlooks adults with down syndrome (ds), who often experience dementia at a younger age and with different diagnostic assessment outcomes. |
2024-03-14 |
2024-03-16 |
Not clear |
| T Hilgenkamp, R Lum, C Roys, T Souza, D Stopka, S Mann, K-Y H. Effects of a 12-week telehealth exercise intervention on gait speed and gait deviations in adults with Down syndrome. Journal of intellectual disability research : JIDR. 2024-03-14. PMID:38481070. |
altered gait patterns and reduced walking speed are commonly reported in adults with down syndrome (ds). |
2024-03-14 |
2024-03-16 |
Not clear |
| Amanallah Soltani, Anna J Esbense. Role of child demographic, executive functions, and behavioral challenges on feelings about parenting among parents of youth with Down syndrome. Research in developmental disabilities. vol 148. 2024-03-13. PMID:38479073. |
living with a child with down syndrome (ds) influences the entire family, including caregivers. |
2024-03-13 |
2024-03-16 |
Not clear |
| Xuran Yang, Qianlan Chen, Zhifeng Pan, Jingmao Cheng, Wenting Zheng, Yingliang Liang, Hui Chen, Guanghui Chen, Wandang Wan. Application of Patient-Based Real-Time Quality Control Based on Artificial Intelligence Monitoring Platform in Continuously Quality Risk Monitoring of Down Syndrome Serum Screening. Journal of clinical laboratory analysis. 2024-03-12. PMID:38468408. |
therefore, we tried to investigate the application of pbrtqc method based on an artificial intelligence monitoring (ai-ma) platform in quality risk monitoring of down syndrome (ds) serum screening. |
2024-03-12 |
2024-03-14 |
Not clear |
| M Moreau, A Madani, R Dard, T Bourgeois, M-P d'Ortho, C Delclaux, N Janel, B Matro. [Use of murine models for the study of obstructive sleep apnea syndrome in Down syndrome]. Revue des maladies respiratoires. 2024-03-09. PMID:38461093. |
down syndrome (ds), or trisomy 21, is a genetic disorder caused by the presence of an extra copy of chromosome 21, leading to various characteristic physical features as well as developmental and cognitive delays. |
2024-03-09 |
2024-03-12 |
Not clear |
| Alessio Faralli, Elisa Fucà, Giulia Lazzaro, Deny Menghini, Stefano Vicari, Floriana Costanz. Transcranial Direct Current Stimulation in neurogenetic syndromes: new treatment perspectives for Down syndrome? Frontiers in cellular neuroscience. vol 18. 2024-03-08. PMID:38456063. |
this perspective review aims to explore the potential neurobiological mechanisms involved in the application of transcranial direct current stimulation (tdcs) for down syndrome (ds), the leading cause of genetically-based intellectual disability. |
2024-03-08 |
2024-03-10 |
Not clear |
| Khusali Gupta, Jan T Czerminski, Jeanne B Lawrenc. Trisomy silencing by XIST: translational prospects and challenges. Human genetics. 2024-03-08. PMID:38459355. |
we first briefly review aspects of xist rna basic biology that are key to its translational relevance, and then discuss recent efforts to develop translational utility of xist for chromosome dosage disorders, particularly down syndrome (ds). |
2024-03-08 |
2024-03-11 |
Not clear |
| Takafumi Uchi, Shingo Konno, Hideo Kihara, Hideki Sugimot. A Multifaceted Approach to Seizure Management in a Patient With Down Syndrome, Obstructive Sleep Apnea, and Hypothyroidism: A Case Report. Cureus. vol 16. issue 3. 2024-03-05. PMID:38440203. |
in this case study, a 16-year-old male with down syndrome (ds) faced persistent nocturnal seizures despite anti-seizure medications and treatment for concurrent hypothyroidism. |
2024-03-05 |
2024-03-07 |
Not clear |
| Rachel S Reeser, Alyssa K Salazar, Kendra M Prutton, James R Roede, Mitchell C VeDepo, Jeffrey G Jaco. Trisomy 21 Alters Cell Proliferation and Migration of iPSC-Derived Cardiomyocytes on Type VI Collagen. Cellular and molecular bioengineering. vol 17. issue 1. 2024-03-04. PMID:38435791. |
individuals with down syndrome (ds) are 2000 times more likely to develop a congenital heart defect (chd) than the typical population freeman et al. |
2024-03-04 |
2024-03-06 |
human |